256518-81-7

Basic information

• Product Name: 3,5-DiMethylMorpholine hydrochloride
• Synonyms: 3,5-DiMethylMorpholine hydrochloride
• CAS NO: 256518-81-7
• Molecular Formula: C6H14ClNO
• Molecular Weight: 151.63446
• Mol File: 256518-81-7.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3,5-DiMethylMorpholine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-DiMethylMorpholine hydrochloride(256518-81-7)
• EPA Substance Registry System: 3,5-DiMethylMorpholine hydrochloride(256518-81-7)

Safety Data

• Hazardous Substances Data: 256518-81-7(Hazardous Substances Data)

Usage

General Description

3,5-DiMethylMorpholine hydrochloride is a chemical compound with the molecular formula C6H14ClNO. It is a hygroscopic, white crystalline powder with a slightly amine-like odor. 3,5-DiMethylMorpholine hydrochloride is commonly used as a catalyst or intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has also been used as a corrosion inhibitor and as a solvent in various chemical reactions. 3,5-DiMethylMorpholine hydrochloride is considered to be toxic if ingested, inhaled, or in contact with skin, and should be handled and stored with appropriate safety measures.

Upstream product

• 2294-46-4 bis(2-hydroxy-1-methylethyl)amine 
• 7664-93-9 sulfuric acid 
• 942309-59-3 meso-3,5-dimethylmorpholine-4-carboxylic acid tert-butyl ester 
• 256518-81-7 C₆H₁₃NO*ClH 
• 942309-58-2 2-[(S)-2-hydroxy-1-methylethylamino]propan-1-ol 
• 154634-95-4 (3S,5S)-4-tert-butoxycarbonyl-3,5-dimethylmorpholine 
• 218595-23-4 C₆H₁₃NO*ClH 
• 2749-11-3 (S)-Alaninol 
• 116-09-6 hydroxy-2-propanone 
• 154596-18-6 (3S,5R)-4-tert-butoxycarbonyl-3,5-dimethylmorpholine 

Downstream Products

• 1542268-31-4 (2S,5R)-3,5-dimethylmorpholine hydrochloride 
• 1542268-31-4 (2S,5S)-3,5-dimethylmorpholine hydrochloride 
• 1542268-31-4 (3R,5R)-3,5-dimethylmorpholine hydrochloride 

Relevant articles and documents

TYK2 INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

NOVEL TRIAZINE COMPOUNDS

The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other pharmaceutical ac-ceptable excipients and use of the compounds to modulate the PI3K/ mTOR pathway

AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS

This invention relates to piperazine derivatives of formula (I), wherein Y is bond or lower alkylene, R1 is aryl which may have substituent(s), R2 is aryl or indolyl, each of which may have substituent(s), R3 is hydrogen or lower alkyl, and R4 is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated diseases in human beings or animals. 1